Skip to content

Effects of mobile application use on adherence to treatment after Angioplasty.

Effects of use mobile application on adherence to treatment after Percutaneous Coronary Intervention: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-34fr3y
Enrollment
Unknown
Registered
2017-10-16
Start date
2017-08-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Intervention group: 50 patients, will receive in the hospital written care plan with the current standard treatment for their cardiovascular health
have installed an application ("My Caregiver") containing the care plan (the registered activities will generate scheduling options as to how often it should be performed by the patient, once the acti
sending four text messages per week through the application over the three-month follow-up period to provide counseling, motivation, information, reinforcing the initial counseling received at the hos
control of risk of cardiovascular disease, based on the Framingham score, which can be accessed through the DCV Risk option in the main menu of the application. Control group: 50 patients, will receiv
have installed a "placebo application" on your smartphone (a web page that can be accessed offline and creates a quick access icon on the smartphone home screen, such as the same name and logo of the
Device
L01.224.900.685

Sponsors

Universidade do Vale do Rio dos Sinos - UNISINOS
Lead Sponsor
Associação Pró-Ensino em Santa Cruz do Sul
Collaborator

Eligibility

Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Have performed percutaneous coronary intervention with stent implantation (regardless of the number of stents and type) for treatment of stable coronary artery disease or for acute event; own smartphone (Android or iOS platform); of both sexes; be over 40 years old.

Exclusion criteria

Exclusion criteria: Patients with motor and / or neurological difficulty to use the smartphone; inability to respond to the questionnaire due to motor and / or neurological difficulty.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be adherence to pharmacological treatment prescribed at hospital discharge, which will be verified in the follow-up contact at three months after discharge. Adherence details and barriers to treatment will be verified using validated self-report questionnaires: MMAS-4 and Brief Medication Questionnaire (BMQ), based on the finding of a variation of at least 20% in pre- and post-intervention measurements.

Secondary

MeasureTime frame
Modification of lifestyle-related risk factors (smoking and physical activity) at three months after hospital discharge, based on the observation of a variation of at least 20% in pre and post-intervention measurements. The habit of smoking and physical activity will be measured by means of a self-report questionnaire. It will be considered smoker the interviewee who reported smoking more than 1 cigarette per day for more than 1 month; and physical activity will be analyzed according to their frequency and leisure duration. Participants will be classified as active (individuals who engage in vigorous activity in three days or more per week with a duration of 20 minutes or more per session; or moderate activity or walking in five days or more per week, lasting 30 minutes or more per session, or any activity added (walking, moderate or vigorous) that results in a frequency equal to or greater than five days per week and lasting equal to or greater than 150 minutes per week); irregularly active (individuals who perform some type of physical activity, but not enough to be classified as active because they do not comply with the frequency or duration recommendations); sedentary (individuals who do not perform physical activity for at least 10 continuous minutes per week).

Countries

Brazil

Contacts

Public ContactMari Gaedke

Universidade do Vale do Rio dos Sinos - UNISINOS

mari_enf@yahoo.com.br+55 51 999835673

Outcome results

None listed

Source: REBEC (via WHO ICTRP)